Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for treatment of hypertriglyceridemia
ChiCTR2200063197Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertriglyceridemia and primary dyslipidaemia comparing Berberine with Placebo (2 arms). Primary endpoint: Triglyceride at week 12. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
berberine
03
Conditions
hypertriglyceridemiaprimary dyslipidaemia
Beyond the preview
Go deeper on ChiCTR2200063197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063197.